top of page

BackTable / Tumor Board / Podcast / Episode #36

Lung Cancer Staging & Systemic Therapies: Recent Advancements

with Dr. Karen Reckamp and Dr. Scott Atay

How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung cancer patient’s treatment plan? In this episode of the 2025 NSCLC Creator Weekend™ series, our tumor board discusses the complexities of lung cancer treatment, including new systemic therapies, lung cancer staging, and the role of molecular diagnostics and liquid biopsies.

This podcast is supported by an educational grant from Johnson & Johnson and Varian.

Johnson & Johnson
Varian
Lung Cancer Staging & Systemic Therapies: Recent Advancements with Dr. Karen Reckamp and Dr. Scott Atay on the BackTable Tumor Board Podcast
Ep 36 Lung Cancer Staging & Systemic Therapies: Recent Advancements with Dr. Karen Reckamp and Dr. Scott Atay
00:00 / 01:04

BackTable, LLC (Producer). (2025, November 18). Ep. 36 – Lung Cancer Staging & Systemic Therapies: Recent Advancements [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Scott Atay on the BackTable Tumor Board Podcast

Dr. Scott Atay is a thoracic surgeon at Keck School of Medicine of the University of Southern California.

Dr. Scott Genshaft on the BackTable Tumor Board Podcast

Dr. Scott Genshaft is an interventional radiologist and the Director of Community Outpatient Interventional Radiology at UCLA Health in Los Angeles, California.

Dr. Venkatesh Krishnasamy on the BackTable VI Podcast

Dr. Venkatesh Krishnasamy is an interventional radiologist at University of Alabama at Birmingham.

Dr. Karen Reckamp on the BackTable Tumor Board Podcast

Dr. Karen Reckamp is a Professor in Medicine, Director of the Division of Medical Oncology at Cedars-Sinai Medical Center in Los Angeles, California.

Synopsis

The panel, featuring specialists from various institutions, discusses the specifics of sequencing therapies, the impact of targeted and immunotherapies, and the nuances of treating different patient profiles, including non-smokers and those with specific genetic mutations. The conversation also touches on the integration of new staging systems, the benefits of multidisciplinary clinics, and the ongoing evolution of cancer treatment trials. The discussion aims to provide clarity on the latest advancements and future directions in managing lung cancer, emphasizing the importance of tailored treatment plans and the potential of emerging technologies.

Timestamps

00:00 - Introduction
05:16 - Molecular Diagnostics and Liquid Biopsy
21:43 - Targeted Therapy Options
27:29 - Managing Toxicities and Treatment Strategies
33:13 - Challenges with Immunotherapy in Special Cases
34:07 - Lung Transplantation in Cancer Patients
48:38 - Multidisciplinary Clinics and Collaboration
01:06:29 - Future Directions

Resources

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

HER2-Positive Metastatic Breast Cancer: Treatment Insights & Protocols with Dr. Erika Hamilton on the BackTable Tumor Board Podcast
NSCLC Treatment: Bispecific Antibodies & EGFR Mutations with Dr. Wade Iams on the BackTable Tumor Board Podcast
Pulse Electrical Field Ablation: Lung Cancer Applications & Benefits with Dr. William Moore and Dr. Daniel Sterman on the BackTable Tumor Board Podcast
Urothelial Carcinoma: Understanding ctDNA & Precision Medicine with Dr. Amanda Nizam and Dr. Brad McGregor on the BackTable Tumor Board Podcast
ESMO Update: Advances in Upper GI Malignancies with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Adenocarcinoma Podcasts
Biopsy Podcasts
Medical Oncology Podcasts
Non-Small Cell Lung Cancer (NSCLC) Podcasts
Oncology Podcasts
Pathology Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page